Risk factors for relapse of erosive GERD during long-term maintenance treatment with proton pump inhibitor: A prospective multicenter study in Japan

Journal of Gastroenterology

Volumn 45, Issue 12, 2010, Pages 1193-1200

  Fujimoto, Kazuma ^b   Hongo, Michio ^a  

^a TOHOKU UNIVERSITY HOSPITAL   (Japan)

^b NONE

Author keywords

Helicobacter pylori; Hiatus hernia; Los Angeles classification; Reflux esophagitis

Indexed keywords

GASTRIN; PROTON PUMP INHIBITOR; RABEPRAZOLE;

ADULT; ARTICLE; BODY MASS; FEMALE; GASTRIN BLOOD LEVEL; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL DISEASE; HELICOBACTER PYLORI; HIATUS HERNIA; HUMAN; INFECTION; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT COMPLIANCE; PRIORITY JOURNAL; RELAPSE; RISK ASSESSMENT; RISK FACTOR; TREATMENT DURATION; TREATMENT RESPONSE;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; AGED; AGED, 80 AND OVER; BODY HEIGHT; ESOPHAGUS; FEMALE; FOLLOW-UP STUDIES; GASTROESOPHAGEAL REFLUX; HERNIA, HIATAL; HUMANS; JAPAN; MALE; MIDDLE AGED; MUCOUS MEMBRANE; PROSPECTIVE STUDIES; PROTON PUMP INHIBITORS; RECURRENCE; RISK FACTORS; SEX FACTORS; TIME FACTORS;

EID: 78651273013     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-010-0276-7     Document Type: Article

References (16)

1. Y Kinoshita C Kawanami K Kishi H Nakata Y Seino T Chiba 1997 Helicobacter pylori independent chronological change in gastric acid secretion in the Japanese Gut 41 452 458 1:STN:280:DyaK1c%2Flt1Kgsg%3D%3D 10.1136/gut.41.4.452 9391241
2. M Miyamoto K Haruma M Kuwabara M Nagano T Okamoto M Tanaka 2008 High incidence of newly developed gastroesophageal reflux disease in the Japanese community: a 6-year follow-up study J Gastroenterol Hepatol 23 393 397 10.1111/j.1440-1746.2007.05043.x 17608639 (Pubitemid 351342060)
3. MJ Collen DA Johnson MJ Sheridan 1994 Basal acid output and gastric acid hypersecretion in gastroesophageal reflux disease. Correlation with ranitidine therapy Dig Dis Sci 39 410 417 1:STN:280:DyaK2c7ksl2jtQ%3D%3D 10.1007/BF02090216 8313826
4. MJ Collen RM Strong 1992 Comparison of omeprazole and ranitidine in treatment of refractory gastroesophageal reflux disease in patients with gastric acid hypersecretion Dig Dis Sci 37 897 903 1:CAS:528:DyaK38XkvVehsrk%3D 10.1007/BF01300388 1587194
5. NJ Bell D Burget CW Howden J Wilkinson RH Hunt 1992 Appropriate acid suppression for the management of gastro-oesophageal reflux disease Digestion 51 Suppl 1 59 67 10.1159/000200917 1397746
6. JG Hatlebakk A Berstad 1997 Prognostic factors for relapse of reflux oesophagitis and symptoms during 12 months of therapy with lansoprazole Aliment Pharmacol Ther 11 1093 1099 1:CAS:528:DyaK1cXhsV2htg%3D%3D 10.1046/j.1365-2036. 1997.00246.x 9663835
7. R Carlsson JP Galmiche J Dent L Lundell L Frison 1997 Prognostic factors influencing relapse of oesophagitis during maintenance therapy with antisecretory drugs: a meta-analysis of long-term omeprazole trials Aliment Pharmacol Ther 11 473 482 1:CAS:528:DyaK2sXks1egtr8%3D 10.1046/j.1365-2036.1997. 00167.x 9218069
8. H Makuuchi 1982 Clinical study of esophageal hiatal hernia: diagnostic criteria and degree classification of hiatal hernia Jpn J Gastroenterol 79 1557 1566 1:STN:280:DyaL3s%2Fos1CjsA%3D%3D (in Japanese with English abstract)
9. M Kusano K Hashizume Y Ehara Y Shimoyama O Kawamura M Mori 2008 Size of hiatus hernia correlates with severity of kyphosis, not with obesity, in elderly Japanese women J Clin Gastroenterol 42 4 345 350 10.1097/MCG.0b013e318037556c 18277907 (Pubitemid 351450617)
10. K Kimura T Takemoto 1969 An endoscopic recognition of the atrophic border and its significance in chronic gastritis Endoscopy 3 87 97 10.1055/s-0028-1098086
11. B Thjodleifsson G Rindi R Fiocca TJ Humphries A Morocutti N Miller, et al. 2003 A randomized, double-blind trial of the efficacy and safety of 10 or 20 mg rabeprazole compared with 20 mg omeprazole in the maintenance of gastro-oesophageal reflux disease over 5 years Aliment Pharmacol Ther 17 343 351 1:CAS:528:DC%2BD3sXitleht7g%3D 10.1046/j.1365-2036.2003.01446.x 12562446 (Pubitemid 36259396)
12. A Caos J Breiter C Perdomo J Barth 2005 Long-term prevention of erosive or ulcerative gastro-oesophageal reflux disease relapse with rabeprazole 10 or 20 mg vs. placebo: results of a 5-year study in the United States Aliment Pharmacol Ther 22 193 202 1:CAS:528:DC%2BD2MXhtVagsrfF 10.1111/j.1365-2036.2005. 02555.x 16091056 (Pubitemid 41153061)
13. S Emerenziani FI Habib M Ribolsi R Caviglia MP Guarino T Petitti, et al. 2006 Effect of hiatal hernia on proximal oesophageal acid clearance in gastro-oesophageal reflux disease patients Aliment Pharmacol Ther 23 751 757 1:STN:280:DC%2BD287ms12lsQ%3D%3D 10.1111/j.1365-2036.2006.02816.x 16556177 (Pubitemid 43344594)
14. T Shimatani M Moriwaki J Xu S Tazuma M Inoue 2006 Acid-suppressive effects of rabeprazole: comparing 10 mg and 20 mg twice daily in Japanese Helicobacter pylori-negative and -positive CYP2C19 extensive metabolisers Dig Liver Dis 38 802 808 1:CAS:528:DC%2BD28XhtlemurfP 10.1016/j.dld.2006.06.002 16843075 (Pubitemid 44430926)
15. K Yamaguchi R Iwakiri M Hara A Kikkawa T Fujise H Ootani, et al. 2008 Reflux esophagitis and Helicobacter pylori infection in patients with scleroderma Intern Med 47 1555 1559 10.2169/internalmedicine.47.1128 18797112
16. R Iwakiri K Fujimoto 2008 Importance of vertebral fracture and body mass index in the pathogenesis of gastroesophgeal reflux disease Intern Med 47 1551 1553 10.2169/internalmedicine.47.1388 18797111